Search clinical trials for: 18F-DX600 PET/CT

Total 1843 results

Peking University Cancer Hospital & Institute

Recruiting

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Solid Tumor

China
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Columbia University

Active, not recruiting

Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers

Metastatic Prostate Cancer

United States
University of Lausanne Hospitals
George Coukos, MD PhD, Head of oncology

Recruiting

68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

Pathological Angiogenesis

Switzerland
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics

Carcinoma, Bronchogenic | Lymphoma, Malignant | Breast Carcinoma | Cancer of Head and Neck | Soft Tissue Neoplasms | Tumors

China
Guy's and St Thomas' NHS Foundation Trust
King's College London

Not yet recruiting

Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET

Cancer | Diagnosis | Resistant Cancer | Response, Acute Phase
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Assessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to Therapy

Prostate Cancer

United States
Wuxi No. 4 People's Hospital

Unknown

Clinic Study of 18F-Al-NOTA-MATBBN in Cancer Diagnostics

Breast Neoplasms | Prostatic Neoplasms
National Cancer Institute (NCI)

Completed

18F-DCFBC PET/CT in Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

United States
Peking University

Unknown

Explore the Clinical Value of 68Ga-DOTANOC PET/CT and 18F-FDG PET/CT in Neuroendocrine Neoplasms

Neuroendocrine Tumors

China
Columbia University

Active, not recruiting

18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

Prostatic Neoplasms

United States
Johns Hopkins University
National Heart, Lung, and Blood Institute (NHLBI)

Recruiting

Biodistribution and Pharmacokinetics of Pretomanid in Tuberculosis Patients Using 18F-Pretomanid PET

Tuberculosis

United States
Wuerzburg University Hospital

Recruiting

PSMA in Gastrointestinal Tumors (GIPSMA, Focusing on Neuroendocrine Neoplasms) (GIPSMA)

Gastrointestinal Cancer

Germany
National Taiwan University Hospital

Recruiting

18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.

Biochemical Relapse Fo Malignant Neoplasm of Prostate

Taiwan
University of Texas Southwestern Medical Center

Withdrawn

Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors

Solid Tumor

United States
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Johns Hopkins University

Completed

Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma

Kidney Cancer | Renal Cell Carcinoma

United States
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)

Withdrawn

18F-CP18 Imaging Studies for Cancer Treatment With Birinapant

Ovarian Neoplasms | Fallopian Tube Neoplasms | Ovarian Cancer | Fallopian Tube Cancer
Grand River Hospital
St. Joseph's Healthcare Hamilton

Unknown

PSMA-based 18F-DCFPyL PET/CT: Evaluating Its Application in Real Life (PEARL)

Prostate Cancer

Canada
prof. dr. Koen Van Laere
Universitaire Ziekenhuizen KU Leuven; KU Leuven; University Hospital, Ghent; Fund...

Not yet recruiting

[18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DBL vs. AD

Parkinson Disease | Alzheimer Disease | Dementia With Lewy Bodies | MSA - Multiple System Atrophy

Belgium
University of Utah
Huntsman Cancer Institute

Not yet recruiting

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Hypoxia | Head and Neck Cancer | Magnetic Resonance Imaging | Cancer Neck
Johns Hopkins University
National Institutes of Health (NIH)

Recruiting

Biodistribution and Pathophysiology Study of 18F-Fluorodeoxysorbitol (18F-FDS) in Diseased Patients

Invasive Fungal Infections | Inflammatory Disease | Oncologic Disease | Enterobacterial Infections

United States
Zhejiang University

Completed

A Study Using 18F-FAPI PET to Evaluate Treatment Response in Pancreatic Adenocarcinoma

Pancreas Adenocarcinoma | Systemic Treatment | 18F-FAPI | Pathologic Response

China
Sir Mortimer B. Davis - Jewish General Hospital

Enrolling by invitation

Prostate Cancer Patient Management With 18F-DCFPyL PET/CT

Prostate Cancer

Canada
University of Edinburgh
British Heart Foundation

Completed

In-vivo Thrombus Imaging With 18F-GP1, a Novel Platelet PET Radiotracer (iThrombus)

Myocardial Infarction | Stroke | Thrombosis | Transient Ischemic Attack | Pulmonary Embolism | STEMI | NSTEMI - Non-ST Segment Elevation MI | DVT | PET | Atherothrombosis | Prosthetic Valve Thrombosis

United Kingdom
University Hospital, Bordeaux

Completed

Evaluation of [18F]-FMISO for Non Operated Glioblastoma (MISOGLIO)

Glioblastoma

France
National Cancer Institute (NCI)

Completed

Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1

Neurofibromatosis | MPNST

United States
University of Aarhus

Recruiting

18F-FDGal PET/CT and PET/MRI in Patients With Hepatocellular Carcinoma

Hepatocellular Carcinoma

Denmark
Hoag Memorial Hospital Presbyterian

Active, not recruiting

18F-fluoroestradiol (FES) PET/CT for Breast Cancer

Breast Cancer

United States
Mara Veenstra, MD
UMC Utrecht; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Not yet recruiting

The Effect of [18F] F-FAPI PET-CT on Management in Patients With Proximal Cholangiocarcinoma (FAPIChol)

Cholangiocarcinoma
SOFIE

Recruiting

Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers (18F-FAPI-74 GI)

Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Cholangiocarcinoma | Pancreatic Ductal Adenocarcinoma | Gastrointestinal Cancers

United States
Memorial Sloan Kettering Cancer Center

Recruiting

Imaging With a PET Agent for Detection of Cancers of the Head and Neck

Head and Neck Cancer

United States
Xiangya Hospital of Central South University

Completed

Synapse Alterations in MSA Patients

Multiple System Atrophy

China
Rigshospitalet, Denmark
Herlev Hospital

Active, not recruiting

Diagnosis of Bone Metabolism in Patients With Inexplicable Lower Back Pain

Lower Back Pain Chronic

Denmark
Lawson Health Research Institute
Ontario Institute for Cancer Research

Completed

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy (PICs)

Prostate Cancer

Canada
Blue Earth Diagnostics
Syne Qua Non Limited; Innovate UK; IND 2 Results LLC

Completed

Fluciclovine (18F) PET/CT in biochemicAL reCurrence Of Prostate caNcer (FALCON)

Cancer of the Prostate

United Kingdom
Peking Union Medical College Hospital

Recruiting

Characterizing Breast Cancer With 18F-FES PET/CT

Breast Cancer

China
University of Utah

Recruiting

[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

Estrogen Receptor Positive Breast Cancer

United States
Radboud University Medical Center
ABX advanced biochemical compounds GmbH

Active, not recruiting

18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer (PICture)

Prostate Cancer

Netherlands
Blue Earth Diagnostics
American College of Radiology; Syne Qua Non Limited; IND 2 Results LLC

Completed

18F Fluciclovine (FACBC) PET/CT in Patients With Rising PSA After Initial Prostate Cancer Treatment (LOCATE)

Prostate Cancer

United States
The Methodist Hospital Research Institute
University of California, Los Angeles

Terminated

Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

Glioma | Glioblastoma | Glioblastoma Multiforme

United States
Western University

Recruiting

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

Metastatic Clear Cell Renal Cell Carcinoma

Canada
University of Arizona
Blue Earth Diagnostics

Not yet recruiting

Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis

Brain Metastases

United States
Peking Union Medical College Hospital
Beijing Normal University

Recruiting

Clinical Applications of (S)-[18F]FBFP PET/CT in Healthy Volunteers and Patients With Central Nervous System Diseases

Patients With Central Nervous System Diseases

China
University of Utah

Recruiting

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Invasive Lobular Breast Carcinoma

United States
Memorial Sloan Kettering Cancer Center

Withdrawn

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Histologically-confirmed Malignancies

United States
Sir Mortimer B. Davis - Jewish General Hospital

Completed

Correlation Between SUV on 18F-Fluorocholine PET/CT and Gleason Score in Prostate Cancer

Prostate Cancer

Canada
Amsterdam UMC, location VUmc

Completed

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET (FORESIGHT)

Breast Cancer

Netherlands
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
Hamad Medical Corporation

Unknown

18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia (PMF/ET-FLT)

Essential Thrombocythemia | Primary Myelofibrosis, Prefibrotic Stage | Primary Myelofibrosis, Fibrotic Stage

Qatar

Search clinical trials for: 18F-DX600 PET/CT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations